Committee approves amendment allowing 92-day supply for injectable testosterone
The Senate Health and Human Services Committee voted to amend House Bill 126 to allow injectable androgen prescriptions for chronic low testosterone to be filled for up to a 92-day supply, matching an existing allowance for topical formulations.
The full story
Chair Rocheford, chair of the Senate Health and Human Services Committee, moved and the committee approved an amendment to House Bill 126 to allow injectable androgen prescriptions for the treatment of chronic low testosterone to be filled for up to a 92-day supply, matching current law for topically applied androgen formulations.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in